Condition: Intrahepatic Cholangiocarcinoma · Sponsor: Memorial Sloan Kettering Cancer Center
This study will compare the safety and effects of HAI floxuridine and dexamethasone combined with the standard chemotherapy drugs gemcitabine and oxaliplatin (GemOx) with those of GemOx alone in people with untreated cholangiocarcinoma that cannot be removed with surgery. The researchers want to find out whether the study treatment works better than the standard chemotherapy to delay progression of disease. For the study treatment to be considered better than the standard treatment, the study treatment should increase the time until progression of disease by an average of 3 months, compared with the usual approach.
This description comes directly from the study's public registry record.
Andrea Cercek, MD · 646-888-4189 · cerceka@mskcc.org
William Jarnagin, MD · 212-639-7601
Always discuss trial participation with your own doctor first.
| National Heart, Lung, and Blood Institute (NIH) (Data Collection Only) | Bethesda, Maryland, United States | Recruiting |
| Washington University (Data Collection Only) | St Louis, Missouri, United States | Recruiting |
| Memorial Sloan Kettering Basking Ridge - Limited Protocol Activities | Basking Ridge, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Monmouth - Limited Protocol Activities | Middletown, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Bergen - Limited Protocol Activities | Montvale, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Commack - Limited Protocol Activities | Commack, New York, United States | Recruiting |
| Memorial Sloan Kettering Westchester - Limited Protocol Activities | Harrison, New York, United States | Recruiting |
| Memorial Sloan Kettering Cancer Center | New York, New York, United States | Recruiting |
| Memorial Sloan Kettering Nassau - Limited Protocol Activities | Uniondale, New York, United States | Recruiting |
| Duke University (Data Collection Only) | Durham, North Carolina, United States | Recruiting |
| Erasmus University (Data Collection Only) | Rotterdam, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04891289